Theravance Bio Ord (TBPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TBPH | LRMR | TRML | ||
| Company | Theravance Bio Ord | Larimar Therapeutics Inc | Tourmaline Bio Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 8.90 | 7.38 | 16.10 | ||
| High | 9.38 | 7.63 | 16.36 | ||
| Low | 8.88 | 7.18 | 15.69 | ||
| Last | 9.37 | 7.61 | 15.92 | ||
| Change | +0.53 | +0.26 | +0.21 | ||
| % Change | +6.00% | +3.54% | +1.34% | ||
| Volume | 455,277 | 220,416 | 469,896 | ||
| 20-Day Average Volume | 490,509 | 309,296 | 460,860 | ||
| Previous Close | 8.84 | 7.35 | 15.71 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 9.29 | 6.89 | 17.70 | ||
| 20-Day Raw Stochastic | 47.55% | 94.97% | 13.54% | ||
| 20-Day Relative Strength | 52.53% | 52.06% | 31.87% | ||
| Weighted Alpha | -14.74 | +10.66 | +34.47 | ||
| Today's Opinion | 48% Sell | 40% Buy | 56% Sell | ||
| Previous Opinion | 80% Sell | 40% Buy | 56% Sell | ||
| Last Month's Opinion | 48% Sell | 40% Buy | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.52% since 04/25/24 | +20.22% since 04/25/24 | -0.50% since 04/25/24 | ||
| Low | 8.40 on 05/01/24 | 6.29 on 04/26/24 | 15.12 on 04/30/24 | ||
| High | 9.38 on 05/02/24 | 7.70 on 05/01/24 | 16.58 on 05/01/24 | ||
| 1-Month | |||||
| %Chg | +2.97% since 04/02/24 | +3.40% since 04/02/24 | -26.97% since 04/02/24 | ||
| Low | 8.40 on 05/01/24 | 5.91 on 04/25/24 | 14.70 on 04/25/24 | ||
| High | 10.44 on 04/12/24 | 8.06 on 04/03/24 | 23.71 on 04/08/24 | ||
| 3-Month | |||||
| %Chg | +5.28% since 02/02/24 | +23.74% since 02/02/24 | -54.72% since 02/02/24 | ||
| Low | 8.21 on 02/08/24 | 5.70 on 02/07/24 | 14.70 on 04/25/24 | ||
| High | 10.44 on 04/12/24 | 13.68 on 02/15/24 | 48.31 on 03/13/24 | ||
| 6-Month | |||||
| %Chg | -4.19% since 11/02/23 | +164.24% since 11/02/23 | -7.60% since 11/02/23 | ||
| Low | 8.21 on 02/08/24 | 2.18 on 11/10/23 | 13.81 on 11/07/23 | ||
| High | 11.71 on 01/04/24 | 13.68 on 02/15/24 | 48.31 on 03/13/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 429,270 | 468,930 | 402,914 | ||
| Shares Outstanding, K | 48,560 | 63,800 | 25,647 | ||
| Annual Sales | 57,420,000 | 0 | 0 | ||
| Annual Net Income | -55,190,000 | -36,950,000 | -42,120,000 | ||
| Last Quarter Sales | 17,570,000 | 0 | 0 | ||
| Last Quarter Net Income | -8,510,000 | -12,990,000 | 2,130,000 | ||
| 60-Month Beta | 0.36 | 0.96 | 2.42 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.03 on 02/26/24 | -0.30 on 03/14/24 | -0.81 on 03/19/24 | ||
| Latest Earnings Date | 05/13/24 | 05/20/24 | 05/20/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||